Provided by Tiger Trade Technology Pte. Ltd.

Dyne Therapeutics, Inc.

24.44
+0.55002.30%
Post-market: 24.44-0.0040-0.02%19:39 EDT
Volume:5.07M
Turnover:123.57M
Market Cap:4.03B
PE:-7.70
High:24.87
Open:23.92
Low:23.70
Close:23.89
52wk High:25.00
52wk Low:8.88
Shares:165.03M
Float Shares:165.00M
Volume Ratio:1.31
T/O Rate:3.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1760
EPS(LYR):-3.4740
ROE:-58.89%
ROA:-32.70%
PB:4.66
PE(LYR):-7.04

Loading ...

Dyne Therapeutics Grants Inducement Equity Awards for 475,100 Shares to 12 New Hires

Reuters
·
Jul 25

Dyne Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 25

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 25

U.S. Earnings Preview: After Market Close July 24

Dow Jones
·
Jul 25

Top News Today: Stocks Decline as Tech Selloff Deepens, Oil Prices Soar

Dow Jones
·
Jul 24

Dyne Therapeutics Closes Upsized Public Offering of 21,045,000 Shares at $20.5 Each

Reuters
·
Jul 24

Press Release: Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Dow Jones
·
Jul 24

Cantor Fitzgerald Initiates Coverage on Dyne Therapeutics With Overweight Rating

MT Newswires Live
·
Jul 23

Dyne Therapeutics Upsized Equity Offering Strengthens Cash Runway

TIPRANKS
·
Jul 23

U.S. Stocks on the Move-ge Vernova, Arrowhead Pharma

Reuters
·
Jul 22

Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Benzinga_recent_news
·
Jul 22

U.S. Stocks on the Move-at&t, Cal-maine Foods, Orasure Technologies

Reuters
·
Jul 22

Dyne Therapeutics Falls After Upsized $375 Mln Share Sale

Reuters
·
Jul 22

Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock

THOMSON REUTERS
·
Jul 22

Stocks to Watch: Super Micro Computer, AAR, Pegasystems, Dyne Therapeutics, Weatherford

Dow Jones
·
Jul 22

Dyne Therapeutics $300M Spot Secondary; price range $20.00-$21.50

TIPRANKS
·
Jul 22

Dyne Therapeutics announces $300M common stock offering

TIPRANKS
·
Jul 22

Dyne Therapeutics Launches USD 300 Million Common Stock Offering

Reuters
·
Jul 22

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Jul 22

Should FDA Priority Review of Dyne’s DMD Drug Candidate Reshape Risk Expectations for Dyne Therapeutics (DYN) Investors?

Simply Wall St.
·
Jul 21